Shanghai Henlius Biotech, Inc. (HKG:2696)

Shanghai Henlius Biotech Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 5, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	24,783	12,881	7,555	6,957	11,984	25,517
Market Cap Growth	70.50%	70.50%	8.59%	-41.95%	-53.03%	15.21%
Enterprise Value	27,800	16,522	11,112	10,233	13,635	25,011
Last Close Price	45.60	23.70	13.90	12.80	22.05	46.95
PE Ratio	28.38	14.75	12.56	-	-	-
Forward PE	27.30	15.91	12.55	-	-	-
PS Ratio	4.07	2.11	1.27	1.91	5.80	36.57
PB Ratio	7.73	4.02	3.13	3.76	4.25	6.72
P/TBV Ratio	-	-	-	-	25.87	12.46
P/FCF Ratio	21.61	11.23	11.94	15.51	-	-
P/OCF Ratio	18.75	9.75	6.54	6.27	108.01	-
EV/Sales Ratio	4.56	2.71	1.87	2.82	6.60	35.84
EV/EBITDA Ratio	21.17	13.36	10.82	-	-	-
EV/EBIT Ratio	30.15	17.92	15.45	-	-	-
EV/FCF Ratio	24.24	14.40	17.57	22.82	-	-
Debt / Equity Ratio	1.21	1.21	1.87	2.25	1.14	0.57
Debt / EBITDA Ratio	2.96	2.96	4.07	-	-	-
Debt / FCF Ratio	3.39	3.39	7.13	9.27	-	-
Asset Turnover	0.56	0.56	0.57	0.40	0.25	0.10
Inventory Turnover	2.07	2.07	1.95	1.44	1.44	0.84
Quick Ratio	0.34	0.34	0.34	0.27	0.35	0.67
Current Ratio	0.50	0.50	0.53	0.44	0.56	0.97
Return on Equity (ROE)	31.52%	31.52%	28.52%	-35.35%	-35.81%	-27.60%
Return on Assets (ROA)	5.28%	5.28%	4.33%	-4.88%	-6.11%	-9.37%
Return on Capital (ROIC)	8.37%	8.37%	7.04%	-7.68%	-8.36%	-11.99%
Return on Capital Employed (ROCE)	15.60%	15.60%	13.50%	-	-	-
Earnings Yield	3.52%	6.78%	7.96%	-11.30%	-10.08%	-4.62%
FCF Yield	4.63%	8.91%	8.37%	6.45%	-3.79%	-5.43%
Buyback Yield / Dilution	-0.02%	-0.02%	-0.25%	-0.59%	-1.75%	-6.52%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.